Aberdeen Group

Aberdeen Group’s Praxis Precision Medicines PRAX Stock Holding History

Aberdeen Group’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55.6M	Buy	172,484 +37,492	+28%	+$11.6M	0.09%	190
2025 Q4	$39.8M	Buy	+134,992	New	+$25.1M	0.06%	258
2025 Q3	–	Sell	-214,056	Closed	-$9M	–	975
2025 Q2	$9M	Buy	214,056 +126,153	+144%	+$4.8M	0.02%	620
2025 Q1	$3.33M	Buy	87,903 +82,904	+1,658%	+$5.18M	0.01%	716
2024 Q4	$385K	Hold	4,999	–	–	﹤0.01%	883
2024 Q3	$288K	Hold	4,999	–	–	﹤0.01%	876
2024 Q2	$207K	Hold	4,999	–	–	﹤0.01%	926
2024 Q1	$305K	Buy	+4,999	New	+$224K	﹤0.01%	900

Other funds holding PRAX

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return